MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.41 USD | -2.06% |
|
-2.57% | +5.86% |
| 09-09 | Phanes Therapeutics Doses First Patient in Trial of Pancreatic Cancer Treatment in Combination With Chemotherapy | MT |
| 09-09 | Merck: positive results in certain lung cancers | CF |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.06% | -2.57% | +0.75% | -11.68% | +5.86% | +5.83% | +56.34% | +38.27% | +90.57% | 293B | ||
| +0.62% | -5.39% | +1.86% | +6.86% | +55.81% | +54.87% | +278.45% | +717.75% | +1,309.48% | 818B | ||
| -1.43% | -5.74% | -2.09% | -11.55% | +25.23% | +27.83% | +178.63% | +426.07% | +560.02% | 582B | ||
| +1.36% | +0.45% | +3.73% | +13.28% | +6.30% | +3.77% | -0.87% | +31.24% | +60.51% | 401B | ||
| +1.56% | +0.06% | +3.42% | +15.94% | +26.75% | +31.81% | +83.11% | +194.48% | +244.90% | 347B | ||
| +0.45% | -4.55% | -3.24% | +12.14% | +9.94% | +5.87% | -21.86% | -0.78% | -1.07% | 254B | ||
| -4.41% | -8.20% | -5.26% | -3.91% | +14.23% | +15.29% | +48.15% | +76.84% | +163.39% | 258B | ||
| -0.51% | -2.25% | +2.42% | +5.07% | +16.74% | +12.20% | +25.94% | +13.48% | +12.65% | 238B | ||
| +1.67% | -2.37% | +1.06% | +6.85% | +13.16% | +25.63% | +51.18% | +61.08% | +137.22% | 175B | ||
| +2.98% | +1.38% | +3.01% | +2.90% | +2.15% | -14.13% | -36.11% | -20.15% | +0.62% | 167B | ||
| -0.38% | +1.27% | +10.11% | +16.69% | +17.36% | +3.46% | +28.67% | +33.75% | +21.92% | 146B | ||
| -0.41% | -2.90% | +3.81% | +16.92% | -5.48% | -20.26% | -23.72% | +0.85% | -3.92% | 98.33B | ||
| +0.57% | +0.22% | +7.48% | +22.36% | -2.27% | +4.17% | +12.12% | +19.36% | -25.23% | 98.57B | ||
| -0.17% | +0.32% | +5.61% | +2.42% | +14.48% | +13.04% | -6.44% | -19.09% | -8.11% | 88.69B | ||
| +0.57% | -7.49% | +5.53% | +36.85% | +23.25% | +47.06% | +57.70% | +157.52% | +527.05% | 75.36B | ||
| -8.64% | -12.32% | -8.39% | -8.86% | +36.23% | +28.07% | +83.77% | +135.77% | +755.87% | 76.77B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| +0.09% | -2.98% | +3.44% | +0.61% | +5.25% | -6.12% | +13.76% | +17.58% | -11.13% | 47.26B | ||
| +0.09% | +2.67% | +5.20% | +21.44% | +22.06% | +20.87% | - | - | - | 46.86B | ||
| +0.34% | +1.48% | +5.02% | +5.69% | -1.50% | +9.78% | -6.09% | -19.05% | +451.50% | 39.82B | ||
| Average | -0.69% | -1.79% | +2.29% | +7.90% | +15.03% | +14.16% | +45.71% | +103.61% | +238.12% | 215.62B | |
| Weighted average by Cap. | -0.66% | -2.80% | +1.36% | +4.98% | +22.47% | +21.80% | +96.68% | +234.12% | +408.43% |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition